Amneal Pharmaceuticals, Inc Class A Common Stock Financials

Values in thousands	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Revenue	$730,518	$702,468	$701,780	$659,191
Gross Profit	262,873	269,558	249,947	238,060
EBITDA	75,793	146,763	151,961	45,709
EBIT		87,802	96,389	-9,819
Net Income	-31,081	-156	5,994	-91,643
Net Change In Cash	730,518	702,468	701,780	659,191
Free Cash Flow		121,062	28,203	-24,170
Cash	110,552	74,006	43,769	46,520
Basic Shares	309,850	309,647	318,957	307,279

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$2,793,957	$2,393,607	$2,212,304	$2,093,669
Gross Profit	1,020,438	820,565	784,708	768,973
EBITDA	249,326	399,759	150,425	450,004
EBIT		170,359	-89,750	216,598
Net Income	-116,886	-83,993	-254,789	20,170
Net Change In Cash	2,793,957	2,393,607	2,212,304	2,093,669
Cost of Revenue			-215,829	-90,484
Free Cash Flow	243,175	276,388	-25,495	189,181
Cash	110,552	91,542	25,976	247,790
Basic Shares	308,978	176,136	150,944	151,821